Bharat Book

Pediatrics Partnering Terms and Agreements

Press Release   •   Dec 16, 2013 10:57 IST

Dec 16, 2013 : Bharat Book Bureau presents the new report, on 'Pediatrics Partnering Terms and Agreements'  also provides a detailed understanding and analysis of how and why companies enter pediatrics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pediatrics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 500 links to online copies of actual pediatrics deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of pediatrics dealmaking and business activities. Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in pediatrics dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.

Chapter 3 provides a review of the leading pediatrics deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of pediatrics deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides comprehensive access to all pediatrics deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all pediatrics partnering deals signed and announced since 2007. The chapter is organized by specific pediatrics therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all pediatrics partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in pediatrics partnering and dealmaking since 2007.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of pediatrics technologies and products.

Pediatrics Partnering Terms and Agreements provides the reader with the following key benefits:

•In-depth understanding of pediatrics deal trends since 2007
•Access pediatrics deal headline, upfront, milestone and royalty data
•Research hundreds of actual contracts between pediatrics partner companies
•Comprehensive access to over 500 links to actual pediatrics deals entered into by the world’s biopharma companies
•Indepth review of pediatrics deals entered into by the leading fifty bigpharma companies
•Benchmark the key deal terms companies have agreed in previous deals
•Identify key terms under which companies partner pediatrics opportunities
•Uncover companies actively partnering pediatrics opportunities

Table of contents:

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in pediatrics dealmaking
2.1. Introduction
2.2. Pediatrics partnering over the years
2.3. Bigpharma pediatrics dealmaking activity
2.4. Bigpharma not active in pediatrics
2.5. Pediatrics partnering by deal type
2.6. Pediatrics partnering by industry sector
2.7. Pediatrics partnering by stage of development
2.8. Pediatrics partnering by technology type
2.9. Pediatrics partnering by pediatrics indication
2.10. Average deal terms for pediatrics
2.10.1 Pediatrics headline values
2.10.2 Pediatrics upfront payments
2.10.3 Pediatrics milestone payments
2.10.4 Pediatrics royalty rates

Chapter 3 – Leading Pediatrics deals
3.1. Introduction
3.2. Top Pediatrics deals by value
3.3. Top Pediatrics deals involving bigpharma

Chapter 4 – Bigpharma pediatrics deals
4.1. Introduction
4.2. How to use bigpharma partnering deals
4.3. Bigpharma pediatrics partnering company profiles
Baxter International
Biogen Idec
Bristol-Myers Squibb
Daiichi Sankyo
Forest Laboratories
Johnson & Johnson
Merck & Co
Merck KGaA
Mitsubishi Tanabe
Novo Nordisk

Chapter 5 – Pediatrics partnering contracts directory
5.1. Introduction
5.2. By deal type
Collaborative R&D
Contract service
5.3. By stage of development
Phase I
Phase III
5.4. By technology type
Biological compounds
Discovery tools
Drug delivery
Natural product
Orphan drug
Small molecules

For more information kindly visit :

Related link :

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: 
Follow us on linked in : 
Our Blog : 

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.